Study on MKNK2 as a potential prognostic and immunological biomarker in pan-cancer.

Authors: Y. -M. ZHANG, J. -K. FAN, X. -Y. WANG, J. LIU, T. LI, X. -S. WANG, X. -J. YANG

Source: European Review for Medical & Pharmacological Sciences; Nov2024, Vol. 28 Issue 22, p4591-4620, 30p